EC Number |
Disease |
PubMed ID |
Title of Publication |
Category |
Confidence Level |
---|
2.7.1.68 | Breast Neoplasms |
9042300 |
Increased signal transduction activity and down-regulation in human cancer cells. |
diagnostic usage ongoing research unassigned |
3 4 0 |
2.7.1.68 | Breast Neoplasms |
20074374 |
Type I gamma phosphatidylinositol phosphate kinase modulates invasion and proliferation and its expression correlates with poor prognosis in breast cancer. |
causal interaction diagnostic usage ongoing research therapeutic application |
4 3 4 1 |
2.7.1.68 | Breast Neoplasms |
20426790 |
Phosphatidylinositol 4,5-bisphosphate and PIP5-kinase Ialpha are required for invadopodia formation in human breast cancer cells. |
causal interaction unassigned |
3 0 |
2.7.1.68 | Breast Neoplasms |
25368680 |
Amplification of Chromosome 1q Genes Encoding the Phosphoinositide Signalling Enzymes PI4KB, AKT3, PIP5K1A and PI3KC2B in Breast Cancer. |
causal interaction unassigned |
3 0 |
2.7.1.68 | Breast Neoplasms |
29851245 |
NEDD4-induced degradative ubiquitination of phosphatidylinositol 4-phosphate 5-kinase ? and its implication in breast cancer cell proliferation. |
causal interaction ongoing research therapeutic application unassigned |
3 1 2 0 |
2.7.1.68 | Carcinoma |
7572337 |
Regulation of signal transduction. |
diagnostic usage ongoing research unassigned |
3 3 0 |
2.7.1.68 | Carcinoma |
7968216 |
Coordinated increase in activities of the signal transduction enzymes PI kinase and PIP kinase in human cancer cells. |
causal interaction diagnostic usage ongoing research unassigned |
2 3 4 0 |
2.7.1.68 | Carcinoma |
9042300 |
Increased signal transduction activity and down-regulation in human cancer cells. |
diagnostic usage ongoing research unassigned |
3 4 0 |
2.7.1.68 | Carcinoma |
9343925 |
Intracellular signalling: phosphatidylinositol lipid metabolism in cancer cells. |
causal interaction diagnostic usage ongoing research unassigned |
2 2 1 0 |
2.7.1.68 | Carcinoma |
9381980 |
Regulation of the signal transduction program by drugs. |
causal interaction diagnostic usage ongoing research therapeutic application |
1 3 3 1 |